Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
about
Optimum duration of regimens for Helicobacter pylori eradicationNew concepts of resistance in the treatment of Helicobacter pylori infectionsCydonia oblonga M., A Medicinal Plant Rich in Phytonutrients for PharmaceuticalsSecond and third line treatment options for Helicobacter pylori eradicationFunctional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala LumpurThe problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin AmericaDoes emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?Polysorbate 80 and Helicobacter pylori: a microbiological and ultrastructural study.The Effect of Probiotic Plus Prebiotic Supplementation on the Tolerance and Efficacy of Helicobacter Pylori Eradication Quadruple Therapy: a Randomized Prospective Double Blind Controlled TrialTreatment of Helicobacter pylori infection: current status and future concepts.Facing resistance of H.pylori infectionContemporary Diagnostic Strategies for the Detection of Helicobacter pylori InfectionOptimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.Clinical practice: diagnosis and evaluation of dyspepsia.Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradicationUpdate on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusEffect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of ColombiaEvidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.Treatment of Helicobacter pylori infection: Past, present and futureConcomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.Empiric therapies for Helicobacter pylori infections.Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients.Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacyEffectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea.The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment FailuresHelicobacter pylori Eradication Therapy: Current Availabilities.Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones.Helicobacter pylori infection in India from a western perspective.The incidence of primary antibiotic resistance of Helicobacter pylori in VietnamThe Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China.A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori EradicationNonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.Antibiotics resistance rate of Helicobacter pylori in BhutanIsolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern chile
P2860
Q24201841-8BEE70DC-5978-4AFA-BD3F-AA59FAA82C9BQ24622513-FB407B7E-FE5F-429B-A01A-3B3D78C33A72Q26738347-29689556-4D15-4DD9-AAF6-E77E2CEA936AQ26829666-A520C2BB-6B55-479A-B6F1-8DD0B732FCE8Q28540466-3E9D2B87-BA92-4B5B-82AA-7B39E1887F48Q30217199-5AB29EAE-50D9-46AC-B767-8AE5F224461AQ30381104-B7AD0E78-2647-4C41-8E04-67DC32A89FF0Q31098820-D931CAF4-C7CF-4E20-B1D8-7893219B620CQ33468909-8E82CC75-E313-4A51-9B7B-9BFA328F24C8Q33594850-8013ED83-DCF9-4FDB-BA08-673DA0ADE9DEQ33596218-EF2BDDA8-0FD9-482D-9EAD-772BEB4B61EFQ33624655-675EBF07-222B-4FAF-8354-2D5FC902C14CQ33626779-F1D5F37A-3E38-47B4-8D75-F3849409EE6CQ33687928-C805E0DB-7377-4EAC-BF08-B3ADFBABF443Q33727000-D343BE2C-C71F-42BB-8BE7-FC30FA40A614Q33735409-5598C7D4-705F-4154-86C4-9641F504695DQ33893567-AE36BC83-8FB8-43E4-BB96-77F5D89CC8F2Q34067951-CE26C4A1-4AC6-462D-A305-9D28CA96CAF7Q34273800-492697B2-74FC-485E-83D2-DC39C31EEF86Q34404967-4754F18A-E02A-4EFE-B6C9-3CF5BB7B4753Q34508830-F340C6E4-D396-46C0-8B31-DB6961F10A6EQ34827671-46F55AD8-F662-43BE-9F65-8AB4AD255615Q35045027-EDB2B345-69F1-4B24-A75D-111B0CA89D3DQ35124976-FD4E2419-9ED7-4876-BC6D-A6D9662AA962Q35169043-427AD73B-6969-492E-B705-D25ABB63D717Q35640492-D4B2536F-0452-4B7C-B91E-83B0B5C4F0EFQ35810200-9DFED799-36B1-4E6C-A7E4-29322B0F297EQ35841617-F3EE01F0-7629-4618-978F-9AAFAE5CAC98Q35855301-2D77FD81-8F2B-411D-B278-18A4274BF198Q35986780-6C93D19F-F0C9-4B85-8433-4EF5944A873CQ36148148-7D4E2824-E221-4A74-A08A-C99DCFFC12C9Q36181286-9F250DF4-A4AA-41B7-921E-2CF85338BFB5Q36290512-16FFE8BB-5F76-49CB-BB58-9F6B77782000Q36449962-76F6B530-7E44-4A4C-96F1-7C819F401E6EQ36565896-0F3E8B48-3283-4274-83F6-D1456DD3277DQ36653595-2DAB49ED-E846-4EA2-BBB2-7095770FC03BQ36993414-D237B8F0-F8C9-4210-9D96-7BA3BA4552D1Q37012409-3A3C9F56-A299-4E86-AD43-F7D7802018F0Q37142225-E7876685-0620-4681-980D-50A5676EEC60Q37162292-50533E10-6F79-4234-8529-B051060EA369
P2860
Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@ast
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@en
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@nl
type
label
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@ast
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@en
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@nl
prefLabel
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@ast
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@en
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@nl
P2860
P921
P1476
Meta-analysis: the effect of a ...... apies for Helicobacter pylori.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2007.03386.X
P407
P577
2007-08-01T00:00:00Z